✦ LIBER ✦

Phase II Study of Accelerated High-Dose Radiotherapy With Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer: Radiation Therapy Oncology Group Protocol 0239

✍ Scribed by Ritsuko Komaki; Rebecca Paulus; David S. Ettinger; Gregory M.M. Videtic; Jeffrey D. Bradley; Bonnie S. Glisson; Corey J. Langer; William T. Sause; Walter J. Curran Jr.; Hak Choy

Book ID: 118457242
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 216 KB
Volume: 83
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.01.075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalation study of thoraci

Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group RTOG

✍ R Komaki; S Swann; D Ettinger; B Glisson; A Sandler; B Movsas; R Byhardt 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 19 KB

P-53 Phase I dose-escalation study of th

P-53 Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group (RTOG) protocol 9712

✍ Komaki, Ritsuko; Swann, Suzanne; Ettinger, David; Glisson, Bonnie; Sandler, Alan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Phase II study of irinotecan plus cispla

Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer

✍ Jeong, Hye Cheol; Lee, Sang Yeub; Lee, Sung Yong; Kim, Je Hyeong; Shin, Chol; Sh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase I/II study of treatment of locally

Phase I/II study of treatment of locally advanced (T3T4) non-oat cell lung cancer with high dose radiotherapy (rapid fractionation): Radiation therapy oncology group study

✍ B. Emami; C.A. Perez; A. Herskovich; M.A. Hederman 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 590 KB

Feasibility and toxicity report from a p

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited-stage small cell lung cancer (LS-SCLC)

✍ Sheikh, H.; Blackhall, F.; Lorigan, P.; Taylor, P.; Ashcroft, L.; Rowbottom, C.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Phase II Study of Erlotinib with Concurr

Phase II Study of Erlotinib with Concurrent Whole-brain Radiation Therapy for Patients with Brain Metastases from Non-small Cell Lung Cancer

✍ J.W. Welsh; E. Kim; A. Amini; P. Allen; J. Chang; R. Komaki; N. Nguyen; J. Holt; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB